Björn Glinghammar
Björn Glinghammar publishes mostly in Molecular Biology, Oncology and Pharmacology, on topics such as Drug-Induced Hepatotoxicity and Protection, Peroxisome Proliferator-Activated Receptors and Liver Disease Diagnosis and Treatment.
- World rank
- #1,305,927 of 7,710,434 ranked researchers
- Rank in Sweden
- #16,836 of 71,437
- Works
- 35
- Citations
- 1.5k
- Citations per work
- 41.5
What does Björn Glinghammar research?
Björn Glinghammar's work is mostly in Medicine (30%), Biochemistry, Genetics and Molecular Biology (20%), Pharmacology, Toxicology and Pharmaceutics (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1439.6%
- Health Sciences1130.3%
- Medicine1130.3%
- Life Sciences1130.1%
- 1Molecular Biology20% of their works
- 2Oncology11% of their works
- 3Pharmacology10% of their works
- 4Surgery6% of their works
- 5Epidemiology6% of their works
- 6Pathology and Forensic Medicine6% of their works
Research topics
- Drug-Induced Hepatotoxicity and Protection
- Peroxisome Proliferator-Activated Receptors
- Liver Disease Diagnosis and Treatment
- Colorectal Cancer Screening and Detection
- Genetic factors in colorectal cancer
- Drug Transport and Resistance Mechanisms
- Inflammatory mediators and NSAID effects
- Cancer, Lipids, and Metabolism
Which keywords describe Björn Glinghammar's research?
The keywords of their largest research topics: Nuclear Receptors, Inflammation, Colorectal Cancer, Drug-Induced Liver Injury, Hepatotoxicity, Peroxisome Proliferator-Activated Receptors, PPARs and Cancer.
- Lipid Metabolism
- Prostaglandins
- Multidrug Resistance
- Screening
- NAFLD
- Microsatellite Instability
- Cancer
- PPARs
- Drug-Induced Liver Injury
- Inflammation
- Nuclear Receptors
- Colorectal Cancer
- Hepatotoxicity
- Peroxisome Proliferator-Activated Receptors
- Colonoscopy
- Molecular Characterization
- NASH
- ATP-dependent Transporters
- Cyclooxygenase-2 Inhibitors
- Fatty Acid Synthase
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Nuclear Receptors102 topics
- Inflammation92 topics
- Colorectal Cancer82 topics
- Drug-Induced Liver Injury71 topic
- Hepatotoxicity71 topic
- PPARs61 topic
- Peroxisome Proliferator-Activated Receptors61 topic
- Cancer52 topics
- Colonoscopy51 topic
- Microsatellite Instability51 topic
- Molecular Characterization51 topic
- NAFLD51 topic
- NASH51 topic
- Screening51 topic
- ATP-dependent Transporters41 topic
- Multidrug Resistance41 topic
- Cyclooxygenase-2 Inhibitors31 topic
- Prostaglandins31 topic
- Fatty Acid Synthase21 topic
- Lipid Metabolism21 topic
Where does Björn Glinghammar work?
Björn Glinghammar's main affiliation in the publication record is Karolinska Institutet, Sweden.
How many publications and citations does Björn Glinghammar have?
OpenAlex counts 35 works and 1,454 citations for Björn Glinghammar, an h-index of 22, ranking #1,305,927 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Björn Glinghammar. Posts are plain text and can be reported.